{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,12]],"date-time":"2025-10-12T19:06:05Z","timestamp":1760295965816},"reference-count":73,"publisher":"Elsevier BV","issue":"2","license":[{"start":{"date-parts":[[2000,8,1]],"date-time":"2000-08-01T00:00:00Z","timestamp":965088000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Gynecologic Oncology"],"published-print":{"date-parts":[[2000,8]]},"DOI":"10.1006\/gyno.2000.5879","type":"journal-article","created":{"date-parts":[[2002,9,17]],"date-time":"2002-09-17T22:50:18Z","timestamp":1032303018000},"page":"113-122","source":"Crossref","is-referenced-by-count":19,"title":["Endocervical Cancer Is Associated with an Increase in the Ligands and Receptors for Transforming Growth Factor-\u03b2 and a Contrasting Decrease in p27Kip1"],"prefix":"10.1006","volume":"78","author":[{"given":"John","family":"Farley","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Karen","family":"Gray","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Lawrence","family":"Nycum","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Margaret","family":"Prentice","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Michael J.","family":"Birrer","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sonia B.","family":"Jakowlew","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1006\/gyno.2000.5879_RF1","doi-asserted-by":"crossref","first-page":"8","DOI":"10.3322\/canjclin.49.1.8","article-title":"Cancer statistics","volume":"49","author":"Landis","year":"1999","journal-title":"CA Cancer J Clin"},{"key":"10.1006\/gyno.2000.5879_RF2","first-page":"912","article-title":"A comparison of adenocarcinoma and squamous cell carcinoma of the cervix","volume":"77","author":"Hopkins","year":"1991","journal-title":"Obstet Gynecol"},{"key":"10.1006\/gyno.2000.5879_RF3","series-title":"Blaustein's Pathology of the Female Genital Tract","first-page":"185","article-title":"Anatomy and Histology of the Cervix","author":"Ferenczy","year":"1994"},{"key":"10.1006\/gyno.2000.5879_RF4","unstructured":"Miller, B, Reis, L, Hankley, B: SEER Cancer Statistics Review1973\u20131990. Bethesda, MD, U.S. Department of Health and Human Service, 1993"},{"key":"10.1006\/gyno.2000.5879_RF5","series-title":"The Epidemiology of Human Papillomavirus and Cervical Cancer","first-page":"3","article-title":"Epidemiology of Cervical Cancer: Overview","author":"Brinton","year":"1992"},{"key":"10.1006\/gyno.2000.5879_RF6","doi-asserted-by":"crossref","first-page":"1272","DOI":"10.1002\/1097-0142(19860915)58:6<1272::AID-CNCR2820580616>3.0.CO;2-B","article-title":"Cervical intraepithelial glandular neoplasia (adenocarcinoma in situ and glandular dysplasia). A correlative study of 23 cases with histologic grading, histochemical analysis of mucins, and immunohistochemical determination of the affinity for four lectins","volume":"58","author":"Gloor","year":"1986","journal-title":"Cancer"},{"key":"10.1006\/gyno.2000.5879_RF7","doi-asserted-by":"crossref","first-page":"167","DOI":"10.1002\/1097-0142(19850701)56:1<167::AID-CNCR2820560126>3.0.CO;2-T","article-title":"Early stage adenocarcinoma of the uterine cervix: histopathologic analysis with consideration of histogenesis","volume":"56","author":"Teshima","year":"1985","journal-title":"Cancer"},{"key":"10.1006\/gyno.2000.5879_RF8","doi-asserted-by":"crossref","first-page":"22","DOI":"10.1136\/jcp.39.1.22","article-title":"Cervical glandular atypia associated with squamous intraepithelial neoplasia: a premalignant lesion?","volume":"39","author":"Brown","year":"1986","journal-title":"J Clin Pathol"},{"key":"10.1006\/gyno.2000.5879_RF9","doi-asserted-by":"crossref","first-page":"8","DOI":"10.1097\/00004347-198903000-00002","article-title":"Human papillomavirus DNA in adenocarcinoma in situ, microinvasive adenocarcinoma of the uterine cervix and coexisting cervical squamous intraepithelial neoplasia","volume":"8","author":"Tase","year":"1989","journal-title":"Int J Gynecol Pathol"},{"key":"10.1006\/gyno.2000.5879_RF10","doi-asserted-by":"crossref","first-page":"321","DOI":"10.1097\/00004347-198912000-00003","article-title":"Human papillomavirus mRNA expression in adenocarcinoma in situ of the uterine cervix","volume":"8","author":"Farnsworth","year":"1989","journal-title":"Int J Gynecol Pathol"},{"key":"10.1006\/gyno.2000.5879_RF11","doi-asserted-by":"crossref","first-page":"246","DOI":"10.1016\/0090-8258(90)90182-K","article-title":"The topography and invasive potential of cervical adenocarcinoma in situ, with and without associated squamous dysplasia","volume":"36","author":"Colgan","year":"1990","journal-title":"Gynecol Oncol"},{"key":"10.1006\/gyno.2000.5879_RF12","doi-asserted-by":"crossref","first-page":"209","DOI":"10.1097\/00004347-199507000-00003","article-title":"Monoclonal antibodies Ki-67 and MIB1 in the distinction of tuboendometrial metaplasia from endocervical adenocarcinoma and adenocarcinoma in situ in formalin-fixed material","volume":"14","author":"McCluggage","year":"1995","journal-title":"Int J Gynecol Pathol"},{"key":"10.1006\/gyno.2000.5879_RF13","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1097\/00004347-199701000-00003","article-title":"Quantitative image analysis of MIB-1 ractivity in inflammatory, hyperplastic, and neoplastic endocervical lesions","volume":"16","author":"Van Hoevan","year":"1997","journal-title":"Int J Gynecol Pathol"},{"key":"10.1006\/gyno.2000.5879_RF14","doi-asserted-by":"crossref","first-page":"1821","DOI":"10.1126\/science.7997877","article-title":"Cell cycle control and cancer","volume":"266","author":"Hartwell","year":"1994","journal-title":"Science"},{"key":"10.1006\/gyno.2000.5879_RF15","series-title":"Handbook of Experimental Pharmacology","doi-asserted-by":"crossref","first-page":"419","DOI":"10.1007\/978-3-642-49295-2_8","article-title":"The Transforming Growth Factor-\u03b2s","author":"Roberts","year":"1990"},{"key":"10.1006\/gyno.2000.5879_RF16","first-page":"81","article-title":"Transforming growth factor-beta","volume":"12","author":"Massague'","year":"1992","journal-title":"Cancer Surv"},{"key":"10.1006\/gyno.2000.5879_RF17","doi-asserted-by":"crossref","first-page":"172","DOI":"10.1016\/0962-8924(94)90202-X","article-title":"The TGF-\u03b2 family and its composite receptors","volume":"4","author":"Massague'","year":"1994","journal-title":"Trends Cell Biol"},{"key":"10.1006\/gyno.2000.5879_RF18","doi-asserted-by":"crossref","first-page":"681","DOI":"10.1016\/0092-8674(93)90489-D","article-title":"Cloning of a receptor that forms a heteromeric complex with the TGF-\u03b2 type II receptor","volume":"75","author":"Franzen","year":"1993","journal-title":"Cell"},{"key":"10.1006\/gyno.2000.5879_RF19","doi-asserted-by":"crossref","first-page":"775","DOI":"10.1016\/0092-8674(92)90152-3","article-title":"Expression cloning of the TGF-\u03b2 type II receptor, a functional transmembrane serine\/threonine kinase","volume":"68","author":"Lin","year":"1992","journal-title":"Cell"},{"key":"10.1006\/gyno.2000.5879_RF20","doi-asserted-by":"crossref","first-page":"18518","DOI":"10.1016\/S0021-9258(17)44782-X","article-title":"Concomitant loss of transforming growth factor-\u03b2 receptors type I and type II in TGF-\u03b2-resistant cell mutants implicates both receptor types in signal transduction","volume":"265","author":"Laiho","year":"1990","journal-title":"J Biol Chem"},{"key":"10.1006\/gyno.2000.5879_RF21","doi-asserted-by":"crossref","first-page":"313","DOI":"10.1016\/S0002-9440(10)65277-7","article-title":"p27Kip1: a multifunctional cyclin-dependent kinase inhibitor with prognostic significance in human cancers","volume":"154","author":"Lloyd","year":"1999","journal-title":"Am J Pathol"},{"key":"10.1006\/gyno.2000.5879_RF22","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1101\/gad.8.1.9","article-title":"p27Kip1, a cyclin-Cdk inhibitor, links transforming growth factor-\u03b2 and contact inhibition to cell cycle arrest","volume":"8","author":"Polyak","year":"1994","journal-title":"Genes Dev"},{"key":"10.1006\/gyno.2000.5879_RF23","doi-asserted-by":"crossref","first-page":"67","DOI":"10.1016\/0092-8674(94)90573-8","article-title":"P27, a novel inhibitor of G1 cyclin-Cdk protein kinase activity, is related to p21","volume":"78","author":"Toyoshima","year":"1994","journal-title":"Cell"},{"key":"10.1006\/gyno.2000.5879_RF24","doi-asserted-by":"crossref","first-page":"227","DOI":"10.1038\/nm0297-227","article-title":"Decreased levels of the cell-cycle inhibitor p27Kip1 protein: prognostic implications in primary breast cancer","volume":"3","author":"Catzavelos","year":"1997","journal-title":"Nat Med"},{"key":"10.1006\/gyno.2000.5879_RF25","first-page":"401","article-title":"Aberrant p27kip1 expression in endocrine and other tumors","volume":"150","author":"Lloyd","year":"1997","journal-title":"Am J Pathol"},{"key":"10.1006\/gyno.2000.5879_RF26","first-page":"114","article-title":"Localization and expression of p27kip1 in multistage colorectal carcinigenesis","volume":"58","author":"Ciaparrone","year":"1998","journal-title":"Cancer Res"},{"key":"10.1006\/gyno.2000.5879_RF27","doi-asserted-by":"crossref","first-page":"230","DOI":"10.1006\/gyno.1998.5003","article-title":"Transforming growth factor-\u03b21 induces apoptosis through down-regulation of c-myc gene overexpression of p27Kip1 protein in cervical carcinoma","volume":"69","author":"Kim","year":"1998","journal-title":"Gynecol Oncol"},{"key":"10.1006\/gyno.2000.5879_RF28","first-page":"1471","article-title":"Differential sensitivity of human colonic adenoma and carcinoma cells to transforming growth factor \u03b2 (TGF \u03b2): conversion of an adenoma cell line to a tumorigenic phenotype is accompanied by a reduced response to the inhibitory effects of TGF-\u03b2","volume":"6","author":"Manning","year":"1991","journal-title":"Oncogene"},{"key":"10.1006\/gyno.2000.5879_RF29","doi-asserted-by":"crossref","first-page":"2588","DOI":"10.1016\/S0021-9258(18)45921-2","article-title":"Inhibition of growth by transforming growth factor-\u03b2 following fusion of two non-responsive human carcinoma cell lines","volume":"267","author":"Geiser","year":"1992","journal-title":"J Biol Chem"},{"key":"10.1006\/gyno.2000.5879_RF30","doi-asserted-by":"crossref","first-page":"1005","DOI":"10.1172\/JCI117048","article-title":"A benign cultured colon adenoma bears three genetically altered colon cancer oncogenes, but progress to tumorigenicity and transforming-beta independence without inactivating the p53 tumor suppressor gene","volume":"93","author":"Markowitz","year":"1994","journal-title":"J Clin Invest"},{"key":"10.1006\/gyno.2000.5879_RF31","first-page":"5545","article-title":"A transforming growth factor \u03b2 receptor type II gene mutation common in colon and gastric but rare in endometrial cancers with microsatellite instability","volume":"55","author":"Myeroff","year":"1995","journal-title":"Cancer Res"},{"key":"10.1006\/gyno.2000.5879_RF32","first-page":"5548","article-title":"Microsatellite instability and mutations of the TGF-\u03b2 type II receptor gene in colorectal cancer","volume":"55","author":"Parsons","year":"1995","journal-title":"Cancer Res"},{"key":"10.1006\/gyno.2000.5879_RF33","first-page":"3982","article-title":"Mis-sense mutations of the transforming growth factor \u03b2 type II receptor in head and neck squamous carcinoma cells","volume":"55","author":"Garrigue-Antar","year":"1995","journal-title":"Cancer Res"},{"key":"10.1006\/gyno.2000.5879_RF34","doi-asserted-by":"crossref","first-page":"22044","DOI":"10.1074\/jbc.270.37.22044","article-title":"Demonstration that mutation of the type II transforming growth factor \u03b2 receptor inactivates its tumor suppressor activity in replication error-positive colon carcinoma cells","volume":"270","author":"Wang","year":"1995","journal-title":"J Biol Chem"},{"key":"10.1006\/gyno.2000.5879_RF35","doi-asserted-by":"crossref","first-page":"283","DOI":"10.1002\/(SICI)1097-0215(19960717)67:2<283::AID-IJC21>3.0.CO;2-B","article-title":"Attenuated ALK5 receptor expression in human pancreatic cancer: correlation with resistance to growth inhibition","volume":"67","author":"Baldwin","year":"1996","journal-title":"Int J Cancer"},{"key":"10.1006\/gyno.2000.5879_RF36","doi-asserted-by":"crossref","first-page":"5877","DOI":"10.1073\/pnas.94.11.5877","article-title":"Loss of functional cell surface transforming growth factor \u03b2 (TGF-\u03b2) type I receptor correlates with insensitivity to TGF-\u03b2 in chronic lymphocytic leukemia","volume":"94","author":"DeCoteau","year":"1997","journal-title":"Proc Natl Acad Sci USA"},{"key":"10.1006\/gyno.2000.5879_RF37","doi-asserted-by":"crossref","first-page":"257","DOI":"10.1016\/S1357-4310(98)01247-7","article-title":"TGF-\u03b2 signaling and cancer: structural and functional consequences of mutations in smads","volume":"4","author":"Hata","year":"1998","journal-title":"Mol Med Today"},{"key":"10.1006\/gyno.2000.5879_RF38","doi-asserted-by":"crossref","first-page":"8772","DOI":"10.1073\/pnas.91.19.8772","article-title":"Genetic changes in the transforming \u03b2 type II receptor gene in human gastric cells: correlation with sensitivity to TGF-\u03b2","volume":"81","author":"Park","year":"1994","journal-title":"Proc Natl Acad Sci USA"},{"key":"10.1006\/gyno.2000.5879_RF39","doi-asserted-by":"crossref","first-page":"26449","DOI":"10.1016\/S0021-9258(18)47215-8","article-title":"Expression of transforming growth factor \u03b2 type II receptor leads to reduced malignancy in human breast cancer MCF-7 cells","volume":"269","author":"Sun","year":"1994","journal-title":"J Biol Chem"},{"key":"10.1006\/gyno.2000.5879_RF40","doi-asserted-by":"crossref","first-page":"4767","DOI":"10.1128\/JVI.64.10.4767-4775.1990","article-title":"Transforming growth factors beta 1 and 2 transcriptionally regulate human papillomavirus (HPV) type 16 early gene expression in HPV-immortalized human genital epithelial cells","volume":"64","author":"Woodworth","year":"1990","journal-title":"J Virol"},{"key":"10.1006\/gyno.2000.5879_RF41","first-page":"7324","article-title":"Differential response of nontumorigenic and tumorigenic human papillomavirus type 16-positive epithelial cells to transforming growth factor \u03b21","volume":"50","author":"Braun","year":"1990","journal-title":"Cancer Res"},{"key":"10.1006\/gyno.2000.5879_RF42","doi-asserted-by":"crossref","first-page":"1188","DOI":"10.1038\/sj.leu.2401477","article-title":"Effects of TGF-\u03b2 on the immune system: implications for cancer immunotherapy","volume":"13","author":"de Visser","year":"1999","journal-title":"Leukemia"},{"key":"10.1006\/gyno.2000.5879_RF43","doi-asserted-by":"crossref","first-page":"137","DOI":"10.1146\/annurev.immunol.16.1.137","article-title":"Regulation of immune responses by TGF-\u03b2","volume":"16","author":"Letterio","year":"1998","journal-title":"Annu Rev Immunol"},{"key":"10.1006\/gyno.2000.5879_RF44","first-page":"1849","article-title":"Transforming growth factor-beta receptors in human cancer cell lines: analysis of transcript, protein and proliferation","volume":"17","author":"Jakowlew","year":"1997","journal-title":"Anticancer Res"},{"key":"10.1006\/gyno.2000.5879_RF45","doi-asserted-by":"crossref","first-page":"149","DOI":"10.3109\/08977199009071501","article-title":"Immunohistochemically detectable TGF-\u03b2 is associated with malignancy in thyroid epithelial neoplasia","volume":"2","author":"Jasani","year":"1990","journal-title":"Growth Factors"},{"key":"10.1006\/gyno.2000.5879_RF46","doi-asserted-by":"crossref","first-page":"681","DOI":"10.1016\/0046-8177(92)90325-W","article-title":"Immunohistochemical study of epidermal growth factor and transforming growth factor-\u03b2 in the penetrating type of early gastric cancer","volume":"23","author":"Hirayama","year":"1992","journal-title":"Hum Pathol"},{"key":"10.1006\/gyno.2000.5879_RF47","unstructured":"Johnson, M, D, Federspiel, C, F, Gold, L, I, Moses HL. Transforming growth factor-\u03b2 and transforming growth factor \u03b2 receptor expression in human meningioma cells. Am J Pathol 141, 633\u2013642, 1992"},{"key":"10.1006\/gyno.2000.5879_RF48","first-page":"6949","article-title":"Immunohistochemical staining for transforming growth factor-\u03b21 associates with disease progression in human breast cancer","volume":"52","author":"Gorsh","year":"1992","journal-title":"Cancer Res"},{"key":"10.1006\/gyno.2000.5879_RF49","first-page":"15","article-title":"effects on growth in vivo and in vitro","volume":"6","author":"Steiner","year":"1992","journal-title":"Mol Endocrinol"},{"key":"10.1006\/gyno.2000.5879_RF50","doi-asserted-by":"crossref","first-page":"1846","DOI":"10.1016\/0016-5085(93)91084-U","article-title":"Enhanced expression of transforming growth factor \u03b2 isoforms in pancreatic cancer correlates with decreased survival","volume":"105","author":"Friess","year":"1993","journal-title":"Gastroenterology"},{"key":"10.1006\/gyno.2000.5879_RF51","doi-asserted-by":"crossref","first-page":"2275","DOI":"10.1002\/1097-0142(19940501)73:9<2275::AID-CNCR2820730907>3.0.CO;2-T","article-title":"Plasma transforming growth factor-\u03b21 in patients with hepatocellular carcinoma","volume":"73","author":"Shirai","year":"1994","journal-title":"Cancer"},{"key":"10.1006\/gyno.2000.5879_RF52","doi-asserted-by":"crossref","first-page":"84","DOI":"10.1006\/gyno.1999.5517","article-title":"Altered expression of CD44 and variant isoforms in human adenocarcinoma of the endocervix during progression","volume":"75","author":"Lu","year":"1999","journal-title":"Gynecol Oncol"},{"key":"10.1006\/gyno.2000.5879_RF53","first-page":"2347","article-title":"Increased expression of transforming growth factor \u03b2 isoforms and basic fibroblast growth factor in complex hyperplasia and adenocarcinoma of the endometrium: evidence for paracrine and autocrine action","volume":"54","author":"Gold","year":"1994","journal-title":"Cancer Res"},{"key":"10.1006\/gyno.2000.5879_RF54","doi-asserted-by":"crossref","first-page":"1260","DOI":"10.1038\/bjc.1998.211","article-title":"Down-regulated expression of transforming growth factor beta 1 mRNA in endometrial carcinoma","volume":"77","author":"Perlino","year":"1998","journal-title":"Br J Cancer"},{"key":"10.1006\/gyno.2000.5879_RF55","doi-asserted-by":"crossref","first-page":"1107","DOI":"10.1002\/(SICI)1097-0142(19960315)77:6<1107::AID-CNCR16>3.0.CO;2-5","article-title":"Altered expression of transforming growth factor-\u03b21 in cervical neoplasia as an early biomarker in carcinogenesis of the uterine cervix","volume":"77","author":"Comerci","year":"1996","journal-title":"Cancer"},{"key":"10.1006\/gyno.2000.5879_RF56","doi-asserted-by":"crossref","first-page":"477","DOI":"10.1006\/gyno.1996.4579","article-title":"Differential transforming growth factor-\u03b2 secretion in adenocarcinoma and squamous cell carcinoma of the cervix","volume":"64","author":"Santin","year":"1997","journal-title":"Gynecol Oncol"},{"key":"10.1006\/gyno.2000.5879_RF57","doi-asserted-by":"crossref","first-page":"10315","DOI":"10.1073\/pnas.90.21.10315","article-title":"Transforming growth factor \u03b2 effects on expression of G1 cyclins and cyclin-dependent kinases","volume":"90","author":"Geng","year":"1993","journal-title":"Proc Natl Acad Sci USA"},{"key":"10.1006\/gyno.2000.5879_RF58","first-page":"1452","article-title":"Transforming growth factor \u03b2 and cell cycle regulation","volume":"55","author":"Alexandrow","year":"1995","journal-title":"Cancer Res"},{"key":"10.1006\/gyno.2000.5879_RF59","doi-asserted-by":"crossref","first-page":"240","DOI":"10.1002\/(SICI)1098-2744(199710)20:2<240::AID-MC11>3.0.CO;2-A","article-title":"Neoplastic transformation of the endocervix associated with downregulation of lactoferrin expression","volume":"20","author":"Farley","year":"1997","journal-title":"Mol Carcinog"},{"key":"10.1006\/gyno.2000.5879_RF60","doi-asserted-by":"crossref","first-page":"223","DOI":"10.1006\/gyno.1999.5346","article-title":"Aberrant expression of the cell cycle associated proteins TP53, MDM2, p21, p27, cdk4, cyclin D1, Rb, and EGFR in cervical carcinomas","volume":"73","author":"Skomedal","year":"1999","journal-title":"Gynecol Oncol"},{"key":"10.1006\/gyno.2000.5879_RF61","doi-asserted-by":"crossref","first-page":"5","DOI":"10.1038\/nm0297-231","article-title":"Increased proteosome-dependent degradation of the cyclin-dependent kinase inhibitor p27 in aggessive colorectal carcinomas","volume":"3","author":"Loda","year":"1997","journal-title":"Nat Med"},{"key":"10.1006\/gyno.2000.5879_RF62","doi-asserted-by":"crossref","first-page":"3088","DOI":"10.1128\/MCB.8.8.3088","article-title":"Selective inhibition of growth-related gene expression in murine keratinocytes by transforming growth factor-\u03b2b","volume":"8","author":"Coffey","year":"1988","journal-title":"Mol Cell Biol"},{"key":"10.1006\/gyno.2000.5879_RF63","doi-asserted-by":"crossref","first-page":"711","DOI":"10.1016\/0006-291X(88)90449-4","article-title":"Modulation of c-myc by transforming growth factor-\u03b2 in human colon carcinoma cells","volume":"150","author":"Mulder","year":"1988","journal-title":"Biochem Biophys Res Commun"},{"key":"10.1006\/gyno.2000.5879_RF64","doi-asserted-by":"crossref","first-page":"1197","DOI":"10.1016\/0006-291X(87)91438-0","article-title":"Suppression of the EGF-dependent induction of c-myc proto-oncogene expression by transforming growth factor \u03b2 in a human breast carcinoma cell line","volume":"144","author":"Fernandez-Pol","year":"1987","journal-title":"Biochem Biophys Res Commun"},{"key":"10.1006\/gyno.2000.5879_RF65","doi-asserted-by":"crossref","first-page":"101","DOI":"10.1002\/jcp.1041350114","article-title":"TGF-\u03b2 inhibits growth factor-induced DNA synthesis in hamster fibroblasts without affecting the early mitogenic events","volume":"135","author":"Chambard","year":"1987","journal-title":"J Cell Physiol"},{"key":"10.1006\/gyno.2000.5879_RF66","doi-asserted-by":"crossref","first-page":"213","DOI":"10.1016\/0014-4827(87)90264-3","article-title":"Transforming growth factor type \u03b2 (TGF-\u03b2) inhibits G1 to S transition, but not activation of human B lymphocytes","volume":"171","author":"Smeland","year":"1987","journal-title":"Exp Cell Res"},{"key":"10.1006\/gyno.2000.5879_RF67","doi-asserted-by":"crossref","first-page":"777","DOI":"10.1016\/0092-8674(90)90188-K","article-title":"TGF-\u03b21 inhibition of c-myc transcription and growth in keratinocytes is abrogated by viral transforming proteins with pRB binding domains","volume":"61","author":"Pietenpol","year":"1990","journal-title":"Cell"},{"key":"10.1006\/gyno.2000.5879_RF68","doi-asserted-by":"crossref","first-page":"506","DOI":"10.1002\/(SICI)1097-0215(19990209)80:4<506::AID-IJC4>3.0.CO;2-E","article-title":"Frequent aberration of the transforming growth factor-\u03b2 receptor II gene in cell lines but no apparent mutation in pre-invasive and invasive carcinomas of the uterine cervix","volume":"80","author":"Chu","year":"1999","journal-title":"Int J Cancer"},{"key":"10.1006\/gyno.2000.5879_RF69","doi-asserted-by":"crossref","first-page":"753","DOI":"10.1146\/annurev.biochem.67.1.753","article-title":"TGF-\u03b2 signal transduction","volume":"67","author":"Massague'","year":"1998","journal-title":"Annu Rev Biochem"},{"key":"10.1006\/gyno.2000.5879_RF70","first-page":"199","article-title":"Cancer of the uterine cervix in Norway by histological type, 1970\u201384","volume":"79","author":"Eide","year":"1987","journal-title":"J Natl Cancer Inst"},{"key":"10.1006\/gyno.2000.5879_RF71","doi-asserted-by":"crossref","first-page":"321","DOI":"10.1038\/bjc.1987.63","article-title":"Squamous and adenocarcinoma of the uterine cervix: a comparison using routine data","volume":"55","author":"Silcocks","year":"1987","journal-title":"Br J Cancer"},{"key":"10.1006\/gyno.2000.5879_RF72","doi-asserted-by":"crossref","first-page":"145","DOI":"10.1016\/0090-8258(89)90032-2","article-title":"Prognosis of the adenocarcinoma of the cervix uteri: a comparative study","volume":"35","author":"Kleine","year":"1989","journal-title":"Gynecol Oncol"},{"key":"10.1006\/gyno.2000.5879_RF73","doi-asserted-by":"crossref","first-page":"152","DOI":"10.1038\/nm0297-152","article-title":"Cancer prognostics: past, present and p27","volume":"3","author":"Steeg","year":"1997","journal-title":"Nat Med"}],"container-title":["Gynecologic Oncology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0090825800958797?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0090825800958797?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2021,5,3]],"date-time":"2021-05-03T03:42:06Z","timestamp":1620013326000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0090825800958797"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2000,8]]},"references-count":73,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2000,8]]}},"alternative-id":["S0090825800958797"],"URL":"https:\/\/doi.org\/10.1006\/gyno.2000.5879","relation":{},"ISSN":["0090-8258"],"issn-type":[{"value":"0090-8258","type":"print"}],"subject":[],"published":{"date-parts":[[2000,8]]}}}